Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3edb9aa141cda1fdc8cb548d0c57f59c http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b545a173759f4f77436d9b406006c6cb |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-05 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4858 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-352 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-185 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-185 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-352 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-05 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 |
filingDate |
2020-01-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0e01eb42254a27de9b5a4b4c6f0aa6d1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_592fe06bfbd4ea4d80850d2fa6cec02f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_73fdd6bc8c4a9149ddc8338d0208901a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0be72b7c6fb3c04b41bb6b5a2f829739 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_23868c65944eaf0783d52e78a9466415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9e853c51c8e55fc2c00a286c0bd0f2c8 |
publicationDate |
2021-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2021121435-A1 |
titleOfInvention |
Methods for treating seizures in epilepsy with a composition comprising cannabinoids |
abstract |
Methods for treating seizures in a subject having epilepsy are provided. The method may comprise administering a pharmaceutical composition comprising CBD and THC to the subject. In some embodiments, the ratio of CBD to THC in the pharmaceutical composition is between about 14:1 and about 17:1. Related uses of the pharmaceutical composition to treat seizures in a subject having epilepsy are also provided. |
priorityDate |
2019-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |